Agonist, Concentration Range | Peak | Ligand Category | Conformation | RMSD | Docking Score (FITTED) | ||||
---|---|---|---|---|---|---|---|---|---|
Selected (FITTED) | Experimental (Crystallography) | ||||||||
% | n | ||||||||
l-Glu, 10 mM | 100 | 43 | Full | Closed | Closed | 0.34 | −5.73 | ||
SYM 2081, 1-3 mM | 102.0 ± 7.7 | 3 | Full | Closed | Closed | 0.24 | −6.52 | ||
QA, 1-3 mM | 90.0 ± 1.1 | 3 | Full | Closed | Closed | 2.0 | −8.70 | ||
l-Cys, 10-60 mM | 73.6 ± 1.9 | 4 | Partial | Closed | −5.60 | ||||
SSC, 1-2 mM | 64.1 ± 7.6 | 5 | Partial | Closed | −8.06 | ||||
HCSA, 10-40 mM | 58.0 ± 5.4 | 5 | Partial | Closed | −6.84 | ||||
KA, 1-3 mM | 39.1 ± 2.0 | 10 | Partial | Intermediate | Intermediate | 0.46 | −8.33 | ||
HC, 10-40 mM | 34.4. ± 3.4 | 8 | Partial | Closed | −6.62 | ||||
CSA, 10-40 mM | 31.72 ± 3.75 | 3 | Partial | Closed | −6.97 | ||||
Dom, 50-150 μM | 15.3 ± 1.9 | 8 | Partial | Open | Open | 1.2 | −8.88 | ||
l-Aminoadipate, 10-40 mM | 14.05 ± 0.19 | 4 | Partial | Closed | −6.70 | ||||
d-Asp, 10 mM | 3.6 ± 1.15 | 6 | Partial | Closed | −6.29 | ||||
l-Asp, 10 mM | 0.95 ± 0.39 | 5 | Partial | Closed | −5.13 | ||||
SOS, 1-20 mM | 0.52 ± 0.7 | 3 | Partial | Closed | −7.24 | ||||
l-Ser, 10 mM | 0.26 ± 0.3 | 3 | Partial | Closed | −5.01 | ||||
d-Ser, 10 mM | 0.05 ± 0.5 | 3 | Partial | Closed |
|
| −4.96 |